{"data":[{"accessionNo":"0001172661-26-003686","formType":"SCHEDULE 13G/A","amendmentNo":4,"issuerCik":"0001709941","issuerName":"BioAge Labs, Inc.","ticker":"BIOA","cusip":"09077V100","securityClass":"Common Stock, par value $0.00001 per share","eventDate":"2026-06-30","reportingPerson":"Cormorant Asset Management, LP","reportingCik":null,"personType":"IA,PN","sharesOwned":2390605,"percentOfClass":5.38,"filedAt":"2026-08-14","canonicalUrl":"https://xoomar.com/markets/stocks/bioa"},{"accessionNo":"0001172661-26-003686","formType":"SCHEDULE 13G/A","amendmentNo":4,"issuerCik":"0001709941","issuerName":"BioAge Labs, Inc.","ticker":"BIOA","cusip":"09077V100","securityClass":"Common Stock, par value $0.00001 per share","eventDate":"2026-06-30","reportingPerson":"Bihua Chen","reportingCik":null,"personType":"HC,IN","sharesOwned":2390605,"percentOfClass":5.38,"filedAt":"2026-08-14","canonicalUrl":"https://xoomar.com/markets/stocks/bioa"},{"accessionNo":"0001172661-26-002218","formType":"SCHEDULE 13G/A","amendmentNo":3,"issuerCik":"0001709941","issuerName":"BioAge Labs, Inc.","ticker":"BIOA","cusip":"09077V100","securityClass":"Common Stock, par value $0.00001 per share","eventDate":"2026-03-31","reportingPerson":"Cormorant Asset Management, LP","reportingCik":null,"personType":"IA,PN","sharesOwned":2890605,"percentOfClass":6.51,"filedAt":"2026-05-15","canonicalUrl":"https://xoomar.com/markets/stocks/bioa"},{"accessionNo":"0001172661-26-002218","formType":"SCHEDULE 13G/A","amendmentNo":3,"issuerCik":"0001709941","issuerName":"BioAge Labs, Inc.","ticker":"BIOA","cusip":"09077V100","securityClass":"Common Stock, par value $0.00001 per share","eventDate":"2026-03-31","reportingPerson":"Bihua Chen","reportingCik":null,"personType":"HC,IN","sharesOwned":2890605,"percentOfClass":6.51,"filedAt":"2026-05-15","canonicalUrl":"https://xoomar.com/markets/stocks/bioa"},{"accessionNo":"0001193125-26-226770","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001709941","issuerName":"BioAge Labs, Inc.","ticker":"BIOA","cusip":"09077V100","securityClass":"Common Stock, par value $0.00001 per share","eventDate":"2026-05-15","reportingPerson":"VK Services, LLC","reportingCik":null,"personType":"OO","sharesOwned":1798702,"percentOfClass":4,"filedAt":"2026-05-15","canonicalUrl":"https://xoomar.com/markets/stocks/bioa"},{"accessionNo":"0001193125-26-226770","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001709941","issuerName":"BioAge Labs, Inc.","ticker":"BIOA","cusip":"09077V100","securityClass":"Common Stock, par value $0.00001 per share","eventDate":"2026-05-15","reportingPerson":"Vinod Khosla","reportingCik":null,"personType":"IN","sharesOwned":1798702,"percentOfClass":4,"filedAt":"2026-05-15","canonicalUrl":"https://xoomar.com/markets/stocks/bioa"},{"accessionNo":"0001193125-26-226770","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001709941","issuerName":"BioAge Labs, Inc.","ticker":"BIOA","cusip":"09077V100","securityClass":"Common Stock, par value $0.00001 per share","eventDate":"2026-05-15","reportingPerson":"Khosla Ventures Opportunity Associates I, LLC","reportingCik":null,"personType":"OO","sharesOwned":1361550,"percentOfClass":3.1,"filedAt":"2026-05-15","canonicalUrl":"https://xoomar.com/markets/stocks/bioa"},{"accessionNo":"0001193125-26-226770","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001709941","issuerName":"BioAge Labs, Inc.","ticker":"BIOA","cusip":"09077V100","securityClass":"Common Stock, par value $0.00001 per share","eventDate":"2026-05-15","reportingPerson":"Khosla Ventures Opportunity I, LP","reportingCik":null,"personType":"PN","sharesOwned":1361550,"percentOfClass":3.1,"filedAt":"2026-05-15","canonicalUrl":"https://xoomar.com/markets/stocks/bioa"},{"accessionNo":"0001193125-26-226770","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001709941","issuerName":"BioAge Labs, Inc.","ticker":"BIOA","cusip":"09077V100","securityClass":"Common Stock, par value $0.00001 per share","eventDate":"2026-05-15","reportingPerson":"Khosla Ventures Associates VI, LLC","reportingCik":null,"personType":"OO","sharesOwned":437152,"percentOfClass":1,"filedAt":"2026-05-15","canonicalUrl":"https://xoomar.com/markets/stocks/bioa"},{"accessionNo":"0001193125-26-226770","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001709941","issuerName":"BioAge Labs, Inc.","ticker":"BIOA","cusip":"09077V100","securityClass":"Common Stock, par value $0.00001 per share","eventDate":"2026-05-15","reportingPerson":"Khosla Ventures VI, LP","reportingCik":null,"personType":"PN","sharesOwned":437152,"percentOfClass":1,"filedAt":"2026-05-15","canonicalUrl":"https://xoomar.com/markets/stocks/bioa"},{"accessionNo":"0002012383-26-001675","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001709941","issuerName":"BioAge Labs, Inc.","ticker":"BIOA","cusip":"09077V100","securityClass":"Common Stock","eventDate":"2026-03-31","reportingPerson":"BlackRock, Inc.","reportingCik":null,"personType":"HC","sharesOwned":2236460,"percentOfClass":5.03,"filedAt":"2026-04-27","canonicalUrl":"https://xoomar.com/markets/stocks/bioa"},{"accessionNo":"0001172661-26-001035","formType":"SCHEDULE 13G/A","amendmentNo":2,"issuerCik":"0001709941","issuerName":"BioAge Labs, Inc.","ticker":"BIOA","cusip":null,"securityClass":"Common Stock, par value $0.00001 per share","eventDate":"2025-12-31","reportingPerson":"Cormorant Asset Management, LP","reportingCik":null,"personType":"IA,PN","sharesOwned":2040605,"percentOfClass":5.69,"filedAt":"2026-02-17","canonicalUrl":"https://xoomar.com/markets/stocks/bioa"},{"accessionNo":"0001172661-26-001035","formType":"SCHEDULE 13G/A","amendmentNo":2,"issuerCik":"0001709941","issuerName":"BioAge Labs, Inc.","ticker":"BIOA","cusip":null,"securityClass":"Common Stock, par value $0.00001 per share","eventDate":"2025-12-31","reportingPerson":"Bihua Chen","reportingCik":null,"personType":"HC,IN","sharesOwned":2040605,"percentOfClass":5.69,"filedAt":"2026-02-17","canonicalUrl":"https://xoomar.com/markets/stocks/bioa"},{"accessionNo":"0001104659-26-016626","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001709941","issuerName":"BioAge Labs, Inc.","ticker":"BIOA","cusip":null,"securityClass":"Common Stock, par value $0.00001 per share","eventDate":"2025-12-31","reportingPerson":"ADAR1 Capital Management, LLC","reportingCik":null,"personType":"IA,OO","sharesOwned":135560,"percentOfClass":0.4,"filedAt":"2026-02-17","canonicalUrl":"https://xoomar.com/markets/stocks/bioa"},{"accessionNo":"0001104659-26-016626","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001709941","issuerName":"BioAge Labs, Inc.","ticker":"BIOA","cusip":null,"securityClass":"Common Stock, par value $0.00001 per share","eventDate":"2025-12-31","reportingPerson":"Daniel Schneeberger","reportingCik":null,"personType":"HC,IN","sharesOwned":135560,"percentOfClass":0.4,"filedAt":"2026-02-17","canonicalUrl":"https://xoomar.com/markets/stocks/bioa"},{"accessionNo":"0002032751-26-000008","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001709941","issuerName":"BIOAGE LABS, INC.","ticker":"BIOA","cusip":null,"securityClass":"Common Stock, par value $0.00001 per share","eventDate":"2025-12-31","reportingPerson":"Kristen Fortney","reportingCik":null,"personType":"IN","sharesOwned":2704736,"percentOfClass":7.2,"filedAt":"2026-02-13","canonicalUrl":"https://xoomar.com/markets/stocks/bioa"}],"updatedAt":"2026-11-03T16:50:09.048Z","source":"xoomar.com","docs":"https://xoomar.com/markets/api","license":"https://xoomar.com/terms","attribution":"Credit XOOMAR with a link to the dataset page on xoomar.com when you republish this data","canonicalUrl":"https://xoomar.com/markets/stocks/bioa","meta":{"source":"SEC","sourceAttribution":"Schedule 13D and 13G data: SEC.","notice":"10 requests a minute without a key, 30 with a free key. Get a free key at https://xoomar.com/signup?utm_source=api, register your app at https://xoomar.com/developers/register?utm_source=api, and credit the data as \"Data: XOOMAR\" together with the sourceAttribution line."}}